超声融合成像在肝脏恶性肿瘤经皮消融中的术者评价:前瞻性研究
结果显示融合成像在91%病例中被判有用,对B超不显影肿瘤更有价值(p<0.001),尤其消融局部复发灶时(p=0.021);
要点
- B超不显影的肝脏肿瘤(尤其局部复发灶)是融合成像获益最大的场景。
- 融合成像可提升术者穿刺消融信心并缩短操作时间,适合纳入术前规划。
核心结论
- 超声融合成像显著提高靶肿瘤检出、增强术者信心并节省时间,尤其适用于局部复发灶的消融。
研究设计与样本
- 流程为先模拟仅B超规划,再将CT/MR图像与超声同步行融合成像引导穿刺与消融,并对术者进行问卷调查。
- 同时比较首次治疗与局部复发情况,参考标准为消融结果与随访。
关键影像表现/征象
- 融合成像在91%病例中被术者判为有用,肿瘤在B超不显影时更有用(p<0.001)。
- 消融局部复发灶时融合成像获益更明显(p=0.021)。
- 68%病例术者信心因融合成像大幅提升,71%病例放射科医生使用融合成像节省了时间,局部复发灶治疗中更明显(p=0.024)。
临床应用与阅片要点
- 对B超难以显示或局部复发的肝脏肿瘤,可优先采用CT/MR-超声融合成像引导消融。
- 规划阶段可先模拟仅B超评估,识别不显影病灶后再启用融合成像以提升检出与信心。
- 融合成像有助于节省操作时间,尤其适用于局部复发灶的穿刺与消融。
局限性
- 术者效用评价基于问卷调查,存在主观性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The purpose of the work described here was to evaluate the use of ultrasound fusion imaging (US-FI) in percutaneous ablation of hepatic malignancies with respect to its global usefulness, improvement of conspicuity, confidence increment, needle route changes, and time savings. Thirty-four hepatic tumors (28 hepatocellular carcinomas, 6 metastases) were prospectively ablated in 16 consecutive patients (64 ± 11 y, 75% males), first simulating B-mode-only planning and then synchronizing computed tomography/magnetic resonance images with US and proceeding to needle insertion and tumor ablation under US-FI guidance. Surveys were administered to the operators to evaluate their perception of US-FI advantages. First treatment and local recurrence were also compared. US-FI was judged useful in 91% of cases and more useful when the tumor was not conspicuous in B-mode (p < 0.001), in particular for ablation of local recurrences (p = 0.021). Forty-one percent of tumors were undetectable at B-mode evaluation, and 93% of them were completely ablated under US-FI guidance. The confidence of the operator was highly increased by US-FI in 68% of cases. In 71% of cases, the radiologist saved time using US-FI, especially in treatment of local recurrences (p = 0.024). In conclusion, US-FI significantly increases the detection of target tumors, improves the confidence of the operator and is a time-saving method, especially in the treatment of local recurrences.
引用
- Beleù A, Drudi A, Giaretta A, et al. Operator Evaluation of Ultrasound Fusion Imaging Usefulness in the Percutaneous Ablation of Hepatic Malignancies: A Prospective Study. Ultrasound Med Biol. 2021. PMID: 34392997. doi:10.1016/j.ultrasmedbio.2021.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。